PP
JUNO

PDT Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

PDT Partners’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-580,400
Closed -$26.5M – 639
2017
Q4 		$26.5M Buy
580,400
+41,600
+8% +$2.08M 0.77% 37
2017
Q3 		$24.2M Buy
+538,800
New +$18.4M 0.8% 26
2015
Q3 		– Sell
-102,658
Closed -$5.47M – 1738
2015
Q2 		$5.47M Buy
+102,658
New +$5.45M 0.14% 179

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PDT Partners's JUNO Position: Q1 2018 in Review

PDT Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 580,400 shares — an estimated $26.5M sold.

PDT Partners first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $26.5M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • PDT Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • PDT Partners sold 580,400 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $26.5M.
  • PDT Partners first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • PDT Partners's Juno Therapeutics, Inc. position peaked at $26.5M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on PDT Partners's 13F filing for Q1 2018, filed 15 May 2018.